2025 Publication
Test Of Rapamycin In Aging Dogs (TRIAD): Study Design And Rationale
Design and rationale for a randomised, placebo-controlled rapamycin trial in healthy middle-aged companion dogs — the first rigorous lifespan-and-healthspan test of a pharmacological ageing intervention in dogs.